Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ595,55971,44
KB649650-1,96
PKN66,866,920,78
Msft-1,31
Nokia3,53753,5485-0,04
IBM-1,58
Daimler AG73,6873,710,29
PFE-2,25
23.04.2021 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 22.04.2021
Ingen Tech (US Other OTC (Pink Sheets))
Závěr k 22.4.2021 Změna (%) Změna (USD) Objem obchodů (ks)
0,0009 0,00 0,00 2 291 274
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 23.04.2021
Popis společnosti
Obecné informace
Název společnostiIngen Technologies Inc
TickerIGNT
Kmenové akcie:Ordinary Shares
RICIGNT.PK
ISIN-
Prioritní akciePreferred Shares
Poslední známé roční výsledky31.05.2013
Poslední známé čtvrtletní výsledky31.08.2013
Počet zaměstnanců k 31.05.2010 5
Akcie v oběhu k 30.11.20151 671 460 837
MěnaUSD
Kontaktní informace
Ulice3410 La Sierra Ave Ste F507
MěstoRIVERSIDE
PSČ92503-5270
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon19 516 887 840
Fax19516888802

Business Summary: Ingen Technologies, Inc. is a holding company. The Company through its subsidiary, Ingen Technologies, Inc., is engaged in medical device manufacturing. The Company manufactures medical equipment for patients suffering with chronic obstructive pulmonary disease (COPD) and requiring oxygen therapy through home healthcare, hospitals, military and government-based medical facilities. The Company manufactures oxygen flow meters and nasal cannulas under Oxyview and Smart Nasal Cannula names. The Company offers both a reusable Oxyview and a disposable Smart Nasal Cannula with Oxyview attached to a nasal cannula. Oxyview is a pneumatic oxygen in-line flow meter. The Smart Nasal Cannula with Oxyview is a disposable nasal cannula that includes the Oxyview assembled and in-line. Oxyview is manufactured in two models: model 206A and model 203A. The Smart Nasal Cannula is available in six models: models 203NCA, 206NCA, 203NCP, 206NCP, 203NCI and 206NCI.
Financial Summary: BRIEF: For the three months ended 31 August 2013, IngenTechnologies Inc revenues increased from $0K to $2K. Netincome totaled $2.4M vs. loss of $604K. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net Income reflectsChange in derivative liability increase from $0K to $2.4M(income), Interest expenses decrease from $569K (expense)to $0K, Selling.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution - NEC
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Surgical and Medical Instrument Manufacturing
SICSurgical And Medical Instruments



  • Poslední aktualizace: 23.04.2021
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Operations Officer, SecretaryGary Tilden5614.02.201103.02.2011
Chief Executive Officer, DirectorDavid Hanson-04.02.201404.02.2014
Chief Financial Officer, DirectorThomas Neavitt-04.02.201429.03.2004